24
November
2014
|
00:00
Europe/Amsterdam

BIOTRONIK Releases New Online Tool to Track MR Conditional Status of Implantable Devices

ProMRI SystemCheck Will Save Time and Streamline Workflow

BERLIN, Germany, Nov 24, 2014 – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the launch of ProMRI® SystemCheck, a new online tool for tracking the ProMRI status of implantable devices. A manufacturer of high quality ProMRI devices since 2010, BIOTRONIK offers the broadest portfolio of devices approved for use with MRIs, and continues to launch new pacemakers and implantable cardioverter-defibrillators (ICDs) every year. It is also the only company to allow heart failure patients with CRT devices to take advantage of MRI scans.

The simple online interface of ProMRI SystemCheck provides an easy reference for those looking to check if a certain pacemaker or ICD system is approved for MR scanning. After selecting the country in an auto-complete menu, users may input the names of pacemakers, ICDs, implantable cardiac monitors (ICMs) and leads. A single click then brings up information about whether these devices are MR conditional. The site also includes a crucial overview of scanning conditions for particular device and lead combinations, as well as required checks for each device before scanning.

“As a pioneer of ProMRI technology, BIOTRONIK has always placed the utmost value on innovative and high quality products and their ease of use,” said Wolf Ruhnke, Vice President at BIOTRONIK. “This is why we invest in innovative online tools like the ProMRI System Check, which enables users to quickly and conveniently obtain important information about our ProMRI devices and leads.”

    About BIOTRONIK:

    At BIOTRONIK, patient well-being is our top priority and has been for 60 years. BIOTRONIK is a leading global medical technology company with products and services that save and improve the lives of millions suffering from heart and blood vessel diseases as well as chronic pain. Driven by a purpose to perfectly match technology with the human body, we are dedicated innovators who develop trusted cardiovascular, endovascular and neuromodulation solutions. BIOTRONIK is headquartered in Berlin, Germany, and is represented in over 100 countries.